About
Ossianix develops advanced CNS-targeted and antibody-based therapeutics leveraging proprietary antibody engineering for neurodegenerative and neurologic diseases.
Explore Ossianix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.